SMC1A and breast cancer: Whilst breast cancer cells treated with 2 mM sodium valproate demonstrated a down-regulation of structural maintenance of chromatin protein 1 (SMC1), DNA methyltransferase 1 (DNMT1) and heterochromatin protein 1 (HP1), proteins known to maintain heterochromatin structures [42].